Abderrahim Oukessou
Bristol-Myers Squibb (United States) · 18 works · 2,695 citations · h-index 8
Top works
- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
- First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
- Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153
- 1311P First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + chemotherapy (chemo) in Asian patients (pts) with advanced non-small cell lung cancer (NSCLC) from CheckMate 9LA
- Management of chronic myeloid leukaemia in clinical practice in France: results of the French subset of patients from the UNIC study
- First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA
- Kinetic of chronic myeloid leukaemia (CML) prevalence in Northern France since the introduction of imatinib
- Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study
- Alternative metrics for assessing clinical benefit with immunotherapy in oncology
- Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma
- A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.
- Heterogeneity of treatment effects in malignant pleural mesothelioma – Authors' reply
- An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival
- Caractéristiques et réponses aux traitements dans le mélanome stade III non opérable et stade IV : étude rétrospective longitudinale MELODY
- A Retrospective Survey of Imatinib Mesylate Treatment for Chronic Myeloid Leukemia in a Northern France Region.
- PCN113 TREATMENT PATTERNS AND OUTCOMES IN THE FRENCH COHORT OF PATIENTS WITH UNRESECTABLE STAGE III OR STAGE IV MELANOMA (MELODY STUDY): A RETROSPECTIVE LONGITUDINAL SURVEY